Nano Pharmaceuticals
Market Cap
₹32 ₹32.00 Cr.
P/E
9.90
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.22
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
15.99 %
Institutions
Institutions
1.79 %
Market cap
Market cap
32.00 Cr
No. of Shareholders
No. of Shareholders
2,557
OPM (%)
OPM (%)
6.82 %
PE
PE
9.90
Prom Holding
Prom Holding
51.15 %
ROCE (%)
ROCE (%)
11.75
ROE (%)
ROE (%)
2.31
Sales
Sales
149 Cr
  • GKB Ophthalmics
  • Centenial Surg. Sut.
  • Kretto Syscon

Nothing to show here

This view can't be shown right now. We're continuously expanding and updating coverage across companies, so please check back again soon.

Nothing to show here

This view can't be shown right now. We're continuously expanding and updating coverage across companies, so please check back again soon.

Price Range

See where the stock is trading versus its 52-week high and low.

Low
45
52W Range
High
78
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on GKB Ophthalmics Ltd. Business

Established in 1981, GKB Ophthalmics is a public listed company specialized in manufacturing single vision, bifocal, and progressive lenses for export to global markets.

GKB Ophthalmics major competitors are Centenial Surg. Sut., Kretto Syscon, Galaxy Medicare, KMS Medisurgi, Amkay Products, Shree Pacetronix, Boston Commerce.
Market Cap of GKB Ophthalmics is ₹33 Crs.
While the median market cap of its peers are ₹35 Crs.

GKB Ophthalmics seems to be less financially stable compared to its competitors.
Altman Z score of GKB Ophthalmics is 2.24 and is ranked 6 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material